Bank Of America Corp Bridge Bio Pharma, Inc. Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 817,742 shares of BBIO stock, worth $20.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

817,742

Previous 424,238 92.76%

Holding current value

$20.7 Million

Previous $17.1 Million 47.64%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $10.8 Million - $15.9 Million	393,504 Added 92.76%	817,742 $25.3 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $7.22 Million - $13.2 Million	-300,470 Reduced 41.46%	424,238 $17.1 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $8.51 Million - $11.5 Million	-640,349 Reduced 46.91%	724,708 $12.5 Million
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $3.72 Million - $9.63 Million	519,245 Added 61.39%	1,365,057 $22.6 Million
Q4 2022 Feb 10, 2023	BUY	$6.74 - $11.52 $2.09 Million - $3.58 Million	310,483 Added 58.0%	845,812 $6.45 Million

Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $195,339 - $304,080	-24,602 Reduced 4.39%	535,329 $5.32 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $3 Million - $6.99 Million	-576,140 Reduced 50.71%	559,931 $5.08 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $3.76 Million - $8.79 Million	512,411 Added 82.16%	1,136,071 $11.5 Million
Q4 2021 Feb 08, 2022	BUY	$11.38 - $53.41 $1.54 Million - $7.24 Million	135,616 Added 27.79%	623,660 $10.4 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $2.55 Million - $3.49 Million	-54,393 Reduced 10.03%	488,044 $22.9 Million
Q2 2021 Sep 13, 2021	BUY	$46.47 - $63.93 $25.2 Million - $34.7 Million	542,437 New	542,437 $33.1 Million

Others Institutions Holding BBIO

# of Institutions

284

Shares Held

170M

Call Options Held

7.41M

Put Options Held

2.61M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Bridge Bio Pharma, Inc. Transaction History